Molecules 2014, 19
2566
MgSO4. Evaporation of the solvent and purification of the residue over silica gel (CHCl3/EtOAc, 50:1)
gave 83.6 mg of product 9 and 133.8 mg of product 11.
1-Azidomethylene-3,5-di[4-methylenelitocholate-1-methylene-(1,2,3-triazol-1-yl)]benzene (9): Oil (34%).
1H-NMR: δH 7.61 (s, 2H, triazole ring), 7.20 (s, 3H, Ar–H), 5.53 (s, 4H, Ph–CH2–triazole ring), 5.21
(s, 4H, O–CH2–triazole ring), 4.35 (s, 2H, CH2–N3), 3.68–3.58 (m, 2H, 3β–H), 0.91(s, 6H,
CH3–19), 0.88 (d, J = 6.0 Hz, 6H, CH3–21), 0.62 (s, 6H, CH3–18). 13C-NMR (CDCl3, TMS, ppm): δC
174.15, 143.53, 137.94, 136.21, 127.85, 124.08, 71.85, 57.24, 56.47, 55.87, 53.89, 53.71, 42.70, 42.06,
40.40, 40.37, 36.40, 35.81, 35.31, 34.54, 31.04, 30.82, 30.50, 28.19, 27.16, 26.40, 26.21, 24.18, 23.36,
20.80, 18.24, 12.01. FT-IR (film) νmax: 3,441, 2,101, 1,735, 1,260, 1,163, 784. ESI-MS (m/z): 1,073.46
[C63H93O6N9+H]+, 1,095.44 [C63H93O6N9+Na]+, 1,106.67 [C63H93O6N9+Cl]−.
1-Azidomethylene-3,5-di[4-methylenecholate-1-methylene-(1,2,3-triazol-1-yl)]benzene (10): Oil (21%).
1H-NMR δH 7.62 (s, 2H, triazole ring), 7.21 and 7.19 (two s, 3H, Ar–H), 5.54 (s, 4H, Ph–CH2–triazole
ring), 5.19 (s, 4H, O–CH2–triazole ring), 4.35 (s, 2H, CH2–N3), 3.93 (s, 2H, 12β–H), 3.82 (s, 2H,
7β–H), 3.47–3.34 (m, 2H, 3β–H), 0.93 (d, J = 6.0 Hz, 6H, CH3–21), 0.87 (s, 6H, CH3–19), 0.64 (s, 6H,
13
CH3–18). C-NMR (CDCl3, TMS, ppm): δC 174.23, 143.60, 137.77, 136.36, 127.81, 127.32, 123.95,
72.97, 71.84, 68.38, 57.45, 53.88, 53.48, 46.71, 46.37, 41.63, 41.45, 39.49, 39.44, 35.29, 34.72, 34.61,
31.02, 30.75, 30.28, 29.67, 28.13, 27.55, 26.35, 23.20, 22.45, 17.24, 12.40, 0.99. FT-IR (film) νmax
:
3,403, 2,100, 1,732, 1,258, 1,169, 732. ESI-MS (m/z): 1,137.46 [C63H93O10N9+H]+, 1,159.46
[C63H93O10N9+Na]+, 1,175.59 [C63H93O10N9+K]+, 1,170.68 [C63H93O10N9+Cl]−.
1
1,3,5-Tris[4-methylenelitocholate-1-methylene-(1,2,3-triazol-1-yl)]benzene (11): Oil (54%). H-NMR:
δH 7.58 (two s, 3H, triazole ring), 7.20 and 7.16 (s, 3H, Ar–H), 5.48 (s, 6H, Ph–CH2–triazole ring),
5.21 (s, 6H, O–CH2–triazole ring), 3.66–3.59 (m, 3H, 3β–H), 0.91(s, 9H, CH3–19), 0.88 (d, J = 6.1 Hz,
9H, CH3–21), 0.62 (s, 9H, CH3–18).13C-NMR (CDCl3, TMS, ppm): δC 174.13, 143.71, 136.76, 127.68,
123.91, 71.82, 57.35, 56.48, 55.89, 53.34, 42.71, 42.06, 40.15, 40.40, 36.42, 35.81, 35.31, 35.30,
34.55, 31.05, 30.84, 30.52, 28.19, 27.16, 26.40, 24.18, 23.36, 20.81, 18.25, 12.01. FT-IR (film) νmax
:
3,358, 1,732, 1,225, 1,163, 757. ESI-MS (m/z): 1,487.05 [C90H135O9N9+H]+, 1,509.04
[C90H135O9N9+Na]+, 1,525.08 [C90H135O9N9+K]+, 1,521.01 [C90H135O9N9+Cl]−.
1,3,5-Tris[4-methylenedeoxycholate-1-methylene-(1,2,3-triazol-1-yl)]benzene (12): Oil (43%).
1H-NMR: δH 8.02 (s, 3H, triazole ring), 7.17 (s, 3H, Ar–H), 5.49 (s, 6H, Ph–CH2–triazole ring), 5.19
(s, 6H, O–CH2–triazole ring), 3.96 (s, 3H,12β–H), 3.61-3.59 (m, 3H, 3β–H), 0.92 (d, J = 6.1 Hz, 9H,
CH3–21), 0.91 (s, 9H, CH3–19), 0.66 (s, 9H, CH3–18). 13C-NMR (CDCl3, TMS, ppm): δC 174.08,
143.72, 136.77, 127.73, 123.81, 73.05, 71.70, 57.42, 53.32, 48.24, 47.10, 46.46, 42.04, 35.97, 35.23,
35.10, 34.08, 33.58, 31.42, 31.07, 30.76, 30.45, 28.64, 27.50, 27.09, 26.12, 23.64, 23.11, 17.24, 12.67.
FT-IR (film) νmax: 3,434, 1,739, 1,255, 1,167, 758. ESI-MS (m/z): 1,535.04 [C90H135O12N9+H]+,
1,557.02 [C90H135O12N9+Na]+, 1,568.98 [C90H135O12N9+Cl]−, 1,612.96 [C90H135O12N9+Br]−.
1
1,3,5-Tris[4-methylenecholate-1-methylene-(1,2,3-triazol-1-yl)]benzene (13): oil (55%). H-NMR: δH
8.17 (s, 3H, triazole ring), 7.26 (s, 3H, Ar–H), 5.57 (s, 6H, Ph–CH2–triazole ring), 5.10 (s, 6H,
O–CH2–triazole ring), 4.33 (d, 3H, J = 3 Hz, 7α–OH), 4.11 (d, 3H, J = 3 Hz, 3α–OH), 4.01 (d, 3H,